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For our Special Survival Guide on HIPAA, see our refresher course: "HIPAA Made Simple: 




The Health Insurance Portability and 
Accountability Act (HIPAA) became law in 1996.  
April 14, 2003 was the compliance date for all 
“covered entities.”  These “covered entities” 
include health care providers, health plans, health 
care clearinghouses, and others having access to 
patient protected health information (PHI) in oral, 
written, electronic, or other format.  PHI is any 
individually identifiable health information 
relating to a person’s past, present, or future 
health condition, provision of health care, and 
payment for that care.  It includes any personal 
identifier such as name, Social Security number, 
address, medical record number, and telephone 
number.1-4 
HIPAA has created a national standard for 
patient privacy and confidentiality throughout the 
continuum of care.  In the two years since its 
implementation, ongoing effort and expense have 
been realized to assure compliance.  Yet, 
questions, confusion, and even fear still exist 
about HIPAA requirements and compliance.4   
 
Patients 
Patients have the right to the protection of their 
personal health information.  They also have the 
right to accurate, complete, thorough, and safe 
communication of that same personal health 
information between health professionals for their 
best care.  
More. . . 
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Patients must be given a “notice of privacy 
practice” statement by each HIPAA “covered 
entity” where the patient discloses protected 
health information.  Patients must receive this 
notice on the first day any treatment or service is 
provided.  Patients are not required to sign that 
they have received this notice but it is usual and 
customary for them to do so.  If they choose not to 
sign or physically document their receipt, they 
must indicate they have received the notice and 
the service provider must document this 
acknowledgment in their records along with a 
reason for refusal to sign.1
Each patient also has the right to access, 
inspect, and obtain a copy of their protected health 
information.  Additionally, they are entitled to 
have the service provider amend their protected 
health information.1
 
Pharmacists, Physicians, and Other 
Healthcare Professionals 
Healthcare providers must be diligent in 
exercising and fulfilling HIPAA requirements.  
This is for their patients’ protection as well as 
their own personal and service providers’ 
protection.  Failure to comply with HIPAA 
privacy law can result in civil or criminal 
penalties.5
Each “covered entity” service provider must 
have an appointed Chief Privacy Officer 
responsible for developing and implementing 
policies and procedures, and assuring compliance 
with all HIPAA provisions.  Service providers 
must also have a person responsible for both 
internal and external customer complaints, 
questions, and information.1  Service provider 
employees must be trained on HIPAA 
requirements in their workplace and new 
employees trained when hired.  All training must 
be documented.1  Ongoing annual training on 
confidentiality issues is helpful for all employees.  
Real or hypothetical case-studies can serve as best 
practice models for education.  An important 
reminder for all employees is that they do not 
have the right to access any PHI unless it is 
needed in the course of their serving patient care 
needs. 
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Those professional caregivers who have a 
direct treatment relationship with the patient are 
legally and ethically authorized to receive, use, 
and transfer information using customary 
communication means.  The law does not restrict 
this form of communication since it is in the best 
interest of the patient.1
At the same time, shared information must be 
the “minimum necessary” for communications 
between individuals involved with indirect care of 
a patient.  Each situation in the continuum of care 
dictates that “minimum necessary” to assure both 
confidential and safety for the patient.  Examples 
of situations where “minimum necessary” 
information should be provided include:  waiting-
room announcements such as a patient’s name 
only, restricted comments when in the presence of 
others who might overhear, discussions with an 
insurance carrier, providing a patient’s 
prescription to a family member or authorized 
friend on-behalf of the patient.  In these instances 
and all others, best judgment is required to protect 
patient confidentiality.1  
Each HIPAA “covered entity,” where the 
patient discloses their personal protected health 
information, must give a “notice of privacy 
practice” statement to the patient.  HIPAA law 
requires that this notice be given in place of a 
formal consent form.  Service providers who use 
consent forms cannot use these in place of the 
formal “notice of privacy.”  Patients must be 
given this notice on the first day any treatment or 
service is provided.  Patients are not required to 
sign that they have received this notice but it is 
usual and customary for them to do so.  If they 
choose not to sign or physically document their 
receipt, they must indicate they have received the 
notice and the service provider must document 
this acknowledgment in their records along with a 
reason for refusal.  The “notice of privacy” 
statement must be specific to the actual practices 
or services provided.  At the time the patient 
receives this notice, the service provider should 
ask the patient about any additional confidentiality 
restrictions for use of their PHI.  These must be 
documented in their records and respected.  All 
documents must be retained for at least six 
years.1,3
More. . . 
Providers might consider discussing the 
patient’s wishes about provider phone messages 
left on the patient’s message center or answering 
machine.  HIPAA does not specifically prohibit 
providers from leaving messages.  To safeguard 
patient privacy, the “minimum necessary” should 
be stated to limit the disclosed information.  A 
provider might consider leaving only a message 
for the patient to call back.6
Providing the personal health information of a 
minor to a parent or legal guardian is allowed by 
HIPAA, if such action is consistent with State or 
other applicable law, and the health care 
professional deems this to be in the best interest of 
the treated minor.1   
Disclosure of PHI is permitted by law in 
certain circumstances.  These include:  disclosures 
for certain public health activities for the purpose 
of preventing or controlling disease, for child 
abuse or neglect, for FDA-regulated product 
safety, quality, recalls, or adverse events, 
exposure to a communicable disease, health 
oversight activities to a health oversight agency, 
for judicial and administrative proceedings, 
certain law enforcement activities, and crimes.1
Providers must furnish patients with a listing 
of any instances when their personal information 
was disclosed outside of their treatment related 
routine disclosure.  This is a patient right.  These 
non-routine disclosures must always be 
documented in their records.  Service providers 
must give the patient this listing within 60 days of 
their request and include requesting name, date, 
address, description, and reason for the disclosure.  
Providers must obtain documented patient 
authorization before they can disclose any PHI not 
authorized under HIPAA provisions.  The 
authorization should contain a description of the 
information disclosed, reason for disclosure, 
individual or agency receiving the information, 
and an expiration date for use of the information.  
If the purpose of the disclosure is for marketing, 
remuneration must be included in the 
documentation.  Authorized documentation must 
be made prior to any disclosure.1,3
Patients requesting access to their personal 
protected health information may be required by 
the service provider to request this access in 
writing.  Patients are allowed access, inspection, 
and copies of their records.  Service providers are 
allowed up to 30 days to act on the patient’s 
request.  Cost-based fees can be charged to the 
patient for supplies, labor, and postage associated 
with copies.1 
Patients requesting that their personal 
protected health information be amended by the 
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service provider may do so.  The provider may 
ask that the request be in writing and the reason 
for amendment stated.  Providers have up to 60 
days to respond.  Providers may refuse to amend 
the information for a variety of reasons including 
that the information is accurate and complete.1 
 
Commentary 
The application of and compliance with 
HIPAA requirements protects both patients and 
health care professionals in assuring 
confidentiality.  The HIPAA Privacy Rule has 
created the legal expression for our professional 
codes of ethics.  Using these ethical guidelines for 
serving patients can alleviate both confusion and 
fear about HIPAA. 
 
 
Users of this document are cautioned to use their own 
professional judgment and consult any other necessary 
or appropriate sources prior to making clinical 
judgments based on the content of this document.  Our 
editors have researched the information with input 
from experts, government agencies, and national 
organizations.  Information and Internet links in this 
article were current as of the date of publication. 
 
References 
1. U.S.  Department of Health and Human Services.  
45 CFR Parts 160,162, and 164.  Regulation Text.  
Fed Regist 2003;1-41. 
2. Palacioz, K.  National health information privacy.  
Pharmacist’s Letter/Prescriber’s Letter 
2002:18(7):180701. 
3. Anon.  HIPAA made simple:  pharmacist’s survival 
guide.  Pharmacist’s Letter 2002:18(9):180916.  
4. Kumekawa J.  HIPAA:  confusion, common sense, 
and codes of ethics.  Online J Issues Nurs 
2005;10:1-3.  
5. Harman LB.  HIPAA:  a few years later.  Online J 
Issues Nurs. 2005;10:1-6. 
6. United States Department of Health and Human 
Services, Health information privacy and civil rights 







=answers.search_nl&p_sort_by=dflt.  (Accessed 











Cite this Detail-Document as follows:  HIPAA confusion and fear about protected health information.  





The most practical knowledge in the least time… 
®
 
3120 West March Lane, P.O. Box 8190, Stockton, CA 95208 ~ TEL (209) 472-2240 ~ FAX (209) 472-2249 
Copyright © 2005 by Therapeutic Research Center 
 
Subscribers to Pharmacist’s Letter and Prescriber’s Letter can get Detail-Documents, like this one, on any 
topic covered in any issue by going to www.pharmacistsletter.com or www.prescribersletter.com
 
